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Targeted disruption of the cell-cycle checkpoint gene ATR leads
to early embryonic lethality in mice
A. de Klein*, M. Muijtjens*, R. van Os*, Y. Verhoeven*, B. Smit*, A.M. Carr†,
A.R. Lehmann† and J.H.J. Hoeijmakers*
Checkpoints of DNA integrity are conserved throughout
evolution, as are the kinases ATM (Ataxia Telangiectasia
mutated) and ATR (Ataxia- and Rad-related), which are
related to phosphatidylinositol (PI) 3-kinase [1–3]. The
ATM gene is not essential, but mutations lead to ataxia
telangiectasia (AT), a pleiotropic disorder characterised
by radiation sensitivity and cellular checkpoint defects in
response to ionising radiation [4–6]. The ATR gene has
not been associated with human syndromes and,
structurally, is more closely related to the canonical
yeast checkpoint genes rad3Sp and MEC1Sc [7,8]. ATR
has been implicated in the response to ultraviolet (UV)
radiation and blocks to DNA synthesis [8–11], and may
phosphorylate p53 [12,13], suggesting that ATM and
ATR may have similar and, perhaps, complementary
roles in cell-cycle control after DNA damage. Here, we
report that targeted inactivation of ATR in mice by
disruption of the kinase domain leads to early
embryonic lethality before embryonic day 8.5 (E8.5).
Heterozygous mice were fertile and had no aberrant
phenotype, despite a lower ATR mRNA level. No
increase was observed in the sensitivity of ATR+/–
embryonic stem (ES) cells to a variety of DNA-damaging
agents. Attempts to target the remaining wild-type ATR
allele in heterozygous ATR+/– ES cells failed, supporting
the idea that loss of both alleles of the ATR gene, even
at the ES-cell level, is lethal. Thus, in contrast to the
closely related checkpoint gene ATM, ATR has an
essential function in early mammalian development.
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Results and discussion
The yeast ATR homologues MEC1Sc and rad3Sp play
pivotal roles in arresting the cell cycle following DNA
damage caused by a wide range of genotoxic agents [1,2].
Hitherto, no human disorder has been associated with
ATR. To assess the impact of ATR mutations in mice, we
isolated genomic clones representing the 3′ end of the
mouse ATR locus (as the 3′ end encodes the critical kinase
domain) and constructed a vector for gene targeting in
mouse ES cells. The positions of exons corresponding to
the coding region around the conserved PI 3-kinase
domain [8] were determined, and this domain was found
to be distributed over the last seven exons (Figure 1a).
The corresponding kinase domain of the human ATM
gene is spread over eight exons that do not coincide [14],
indicating that the intron/exon structures are not strongly
conserved between these closely related genes.
Fluorescence in situ hybridisation (FISH) localised the
mouse ATR gene to chromosome 9, band E4/F (Figure 2a),
which is close to the mouse ATM locus. To exclude the pos-
sibility of cross-hybridisation, ATR and ATM genomic
probes were used in a dual-colour FISH. This demon-
strated (Figure 2b) that the ATM gene was indeed located
slightly more proximal on mouse chromosome 9 in band C,
as previously reported [15]. The Davis human/mouse
homology map (http://www.nbci.nlm.nih.gov/homology)
confirmed the presence of several human regions syntenic
to mouse chromosome 9, including human chromosome
11q23 (the position of the ATM gene) [16] and human chro-
mosome 3q (where human ATR is located) [7,8].
To inactivate ATR, an nls–lacZ/TK–neo cassette was
inserted in-frame into the ATR gene in the PstI site located
just 5′ to the sequence encoding the most highly conserved
part of the kinase domain (Figure 1a), thus disrupting this
important portion of the encoded protein. The linearised
plasmid was electroporated into E14 129/Ola ES cells, and
205 neomycin-resistant clones were isolated and screened
for homologous integration. Six clones (Figure 1b) were
found in which nls–lacZ/TK–neo cassette had correctly
replaced the segment encoding the PI 3-kinase domain of
ATR. Four independent ES cell clones (designated B9,
B19, J20 and D3) were injected into mouse 129/Sv blasto-
cysts, yielding 39 chimaeras in total. Two of the chimaeric
mice (derived from different ES cell transformants) gave
offspring with germ-line transmission (Figure 1c), and mice
heterozygous for the targeted ATR gene were established.
Both male and female ATR+/– mice were fertile but, when
ATR+/– mice were interbred, homozygous mutants for the
targeted ATR allele were absent from the large number of
offspring analysed (Table 1). The observed ratio of ATR+/–
to wild-type mice was close to 2:1, indicating embryonic
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lethality of the ATR-deficient phenotype. Heterozygous
matings were analysed at E10.5 and E8.5, but again no
ATR–/– embryos were found. At both time-points, we
observed a significantly high proportion of residual placen-
tas containing no embryos. Unfortunately, because of the
presence of maternal tissue, unequivocal genotyping was
not possible, but the residual placentas indicate post-
implantation lethality, that is, later than E4.5. We are cur-
rently establishing ES cell lines from blastocysts of matings
between ATR+/– females and ATR+/– males.
As a complementary approach to generate an ATR-defi-
cient cell line, we attempted to inactivate the remaining
wild-type ATR allele in the neomycin-resistant ATR+/– ES
cells by using an ATR construct carrying a marker for
hygromycin resistance (PGK–hygro) (Figure 1a). In wild-
type ES cells, homologous recombination yielded 7 (out
of 250) correctly targeted ES cell clones, which is compa-
rable to the frequency observed before with the
nls–lacZ/TK–neo cassette. Extensive efforts to inactivate
the remaining wild-type allele in the neomycin-resistant
ATR+/– ES cells failed, however, although retargeting of
the ATR/nls–lacZ/TK–neo allele was observed. Among the
639 tested hygromycin-resistant ES cell transformants, at
least eight ATR–/– clones would have been expected. The
absence of ATR–/– transformants was, statistically, highly
significant (p = < 0.001, Student’s t-test), suggesting that
ATR is essential for the viability of ES cells.
Analysis of heterozygous ATM mice and mouse embryonic
fibroblasts (MEFs) suggests that ATM haplo-insufficiency
results in increased sensitivity to ionising radiation [5,6,17]
The ATR gene is expressed at very low levels and its 10 kb
transcript cannot be detected by northern blot analysis in
most tissues, with the notable exception of the testis [18].
Therefore, the effect of targeting one of the ATR alleles at
the molecular level was investigated using this tissue. As
shown by the northern blot in Figure 1d, the amount of
ATR mRNA was decreased in the testes of ATR+/– mice
compared with wild-type mice. If, as in the case of ATM,
this was also reflected at the protein level, we could infer
that a 50% reduction of the ATR product does not result in
any obvious phenotype at the level of the intact organism.
Both male and female ATR+/– mice were fertile, developed
normally (body weight) and produced ATR+/– offspring in a
Mendelian fashion. The survival of the ATR+/– mice after
one year (> 95%) was not significantly different from wild-
type mice, nor did we see any tumours developing in the
ATR+/– mice during this period. We have not excluded the
possibility that differences in cancer predisposition
become apparent later in life or after chronic or acute treat-
ment with DNA-damaging agents.
The ATR–lacZ fusion transcript, expected to be 3 kb
larger than the wild-type transcript, was not visible by
northern analysis with an ATR probe (Figure 1d) or with
an nls–lacZ/TK–neo probe (data not shown). Using reverse
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Figure 1
Targeted disruption of the murine ATR locus.
(a) Genomic structure of the 3′ end of the
ATR locus (top), and the ATR loci targeted
with nls–lacZ/TK–neo (middle) or
PGK–hygro (bottom). Dark grey boxes, exons;
unshaded boxes, the inserted
nls–lacZ/TK–neo [10] and PGK–hygro
cassettes; light grey boxes, DNA probes;
arrows above the wild-type locus, the 5′ and
3′ flanking regions of the targeting constructs;
small arrows, PCR primers (see the
Supplementary material); E, EcoRI; V, EcoRV;
H, HindIII; P, PstI; S, SphI; X, XbaI.
(b) Neomycin-resistant ES cell clones
(targeted with nls–lacZ/TK–neo) were
digested with HindIII and EcoRV, blotted and
probed with the 1 kb 3′ PCR probe. ES cell
clones B10, J20, I17, D3, B19 and B9 were
correctly recombined and contained the
11 kb nls–lacZ/TK–neo-targeted (neo) allele.
The E14 parental ES cell clone showed only
the 13 kb wild-type allele. (c) Germ-line
transmission of the B19 chimaeric mouse.
Offspring were genotyped using the P1, P2
and P3 primers. The position of the 375 bp
wild-type ATR and the 511 bp ATR–neo
(neo) fragment are indicated. (d) Expression
of the ATR gene in mouse tissues. Total RNA
(20 µg) extracted from the indicated tissues
of a wild-type and ATR+/– mouse was
electrophoresed, blotted and hybridised with
a 32P-labelled 0.8 kb ATR cDNA probe. The
ethidium-bromide-stained gel before blotting
(bottom) was used as a control for loading.
The 28S and 18S ribosomal RNA bands and
the 10 kb ATR mRNA transcript are indicated.
Te, testis; Sp, spleen; Ki, kidney; Br, brain.
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transcription (RT)–PCR, ATR–lacZ fusion mRNAs were
detected in testes of ATR+/– mice and in ATR+/– ES cells.
Alternatively spliced ATR mRNAs that skipped the
nls–lacZ/TK–neo exon were not observed. The ATR–lacZ
fusion transcript was, however, unstable or expressed at
very low levels as, unlike previous positive results with
this nls–lacZ/TK–neo cassette [19], we did not observe
any β-galactosidase activity in the testes of ATR+/– mice
or ES cells.
In view of the increased sensitivity of ATM heterozygotes,
we examined whether the heterozygous ES cell clones dis-
played altered sensitivity to DNA-damaging agents. Expo-
sure to UV radiation, to the DNA crosslinking agent
mitomycin C, or to γ-irradiation, failed to cause any signifi-
cant differences in survival for any of the tested neomycin-
(Figure 3) or hygromycin-resistant ES cell clones.
In contrast to ATR, the closely related checkpoint gene
ATM is not essential during early embryogenesis [4–6].
Mutants of the budding yeast and fission yeast ATM ortho-
logues TEL1Sc and tel1Sp, respectively, display a much less
severe phenotype than mutants with loss of the ATR ortho-
logues MEC1Sc or rad3Sp [1,2,20]. ATM-deficient mice are
viable and display many aspects of the pleiotropic pheno-
type of AT patients, including infertility, sensitivity to ion-
ising radiation and cancer susceptibility [5,6]. Premature
senescence of ATM-deficient mouse embryonic fibro-
blasts is rescued in a p53-deficient background [21].
Although the viability of cells with a dominant-negative
ATR mutation was not dependent on the presence of
functional p53 [10], absence of p53 might have an effect
on the lethality of ATR–/– embryos.
Our work demonstrates that ATR is an essential gene,
required for embryogenesis and probably general cell prolif-
eration. This is consistent with the observations that high-
level dominant-negative ATR expression causes cell
death [10,11] and that modest overexpression of wild-type
ATR inhibits MyoD-induced differentiation and cell-cycle
abnormalities [9]. At present, it is not clear whether embry-
onic lethality and the effect on cell differentiation and pro-
liferation are intrinsic to its checkpoint function. Perhaps, as
for the MEC1Sc gene [1,22], a more subtle mutation or
Cre–lox-mediated conditional mutation of ATR in mouse
tissues will enable the different functions of ATR to be seg-
regated and studied. An embryonic lethal phenotype has
also been observed in an independent ATR knockout [23]. 
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Table 1
Genotyping of offspring and embryos from matings of heterozygous ATR mice.
Number of litters Total number Genotype No result
+/+ +/– –/–
Offspring 46 301 99 (75.3) 202 (150.5) 0 (75.3) –
E10.5 4 30* 10 (7) 18 (14) 0 (7) 2
E8.5 3 20† 5 (4.5) 13 (9) 0 (4.5) 2
These numbers exclude the 7* or 6† residual placentas that were not genotyped. The numbers within parentheses indicate the number of offspring
expected on the basis of Mendelian inheritance. 
Figure 2
Localisation of ATR, and colocalisation of ATR and ATM, on mouse
chromosome 9. (a) Metaphase spreads of the mouse erythroid Red8
cell line were hybridised with a biotinylated murine ATR cosmid clone
as described [24]. A specific hybridisation signal (arrowheads) was
detected on mouse chromosome 9. Counterstaining (not shown) with
4,6-diamidino-2-phenylindole (DAPI) revealed the chromosome
banding pattern, and the identity of chromosome 9 was confirmed
using control chromosome 9 probes. (b) Specific FISH signals on
chromosome 9 using a biotinylated murine ATR cosmid probe alone
(right), or biotinylated murine ATR and ATM cosmid probes used
simultaneously (left). The signals of the ATR and ATM genes are
indicated on the chromosomes and in the diagrams of the
chromosome 9 banding pattern.
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Supplementary material
Supplementary material including additional methodological detail, a
figure showing expression of the ATR gene and ATR–lacZ fusion tran-
scripts in different mouse tissues and ES cells, and a figure showing
the murine ATR cDNA sequence is available at http://current-
biology.com/supmat/supmatin.htm.
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Figure 3
Effect of DNA-damaging agents on wild-type and nls–lacZ/TK–neo-
targeted ES cells. Clonogenic survival assay after treatment with
(a) increasing concentrations of the DNA crosslinking agent
mitomycin C, or increasing doses of (b) 137Cs γ-irradiation and
(c) 254 nm UV-C light. The percentage of surviving cells, as
measured by their colony-forming ability, was plotted as a
function of the indicated concentration of mitomycin C , or dose
of γ- or UV-radiation. All measurements were performed in
triplicate as described [25] and the standard error of the mean
are indicated.
bb10h50.qxd  04/17/2000  01:08  Page 482
